| 1 |
32498555 | Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease. | 2021 Mar 10 |
1 |
| 2 |
32498290 | (-)-Loliolide Isolated from Sargassum horneri Protects against Fine Dust-Induced Oxidative Stress in Human Keratinocytes. | 2020 Jun 2 |
2 |
| 3 |
30538129 | High-mobility group box 1 links sensing of reactive oxygen species by huntingtin to its nuclear entry. | 2019 Feb 8 |
10 |
| 4 |
30632085 | Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review. | 2019 Apr |
2 |
| 5 |
30256717 | A patient-derived cellular model for Huntington's disease reveals phenotypes at clinically relevant CAG lengths. | 2018 Nov 15 |
2 |
| 6 |
28733489 | Interaction of misfolded proteins and mitochondria in neurodegenerative disorders. | 2017 Aug |
1 |
| 7 |
21984825 | In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. | 2011 Dec 30 |
1 |
| 8 |
20491647 | Huntingtons Disease: The Value of Transcranial Meganetic Stimulation | 2010 |
2 |
| 9 |
16817855 | Analysis of oxidative events induced by expanded polyglutamine huntingtin exon 1 that are differentially restored by expression of heat shock proteins or treatment with an antioxidant. | 2006 Jul |
1 |
| 10 |
11978772 | Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. | 2002 May 1 |
3 |